A Clinical Study in Children and Adolescents With Mild to Moderate Atopic Dermatitis

• Status: Completed
• Trial end date: 2008-09-01
• Target enrollment: 0
• Participant gender: All

Summary

To show therapeutic efficacy of Zarzenda cream compared to Elidel cream in children and adolescents with mild to moderate atopic dermatitis

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bayer
• Treatments: Pimecrolimus

Criteria

Inclusion Criteria:

• male and female children and adolescents (aged 2 - 17)

• mild to moderate atopic dermatitis

• patients in whom a treatment with topical corticosteroids in not recommended or possible

• wash out periods to be observed

Exclusion Criteria:

• known allergy to one of the two treatments

• known immunodeficiency

• known hepatic or renal insufficiency

• acute skin infections